<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 58-year old man with a history of <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> and <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (with recurrent <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> and therapy-refractory autoimmune thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo>) presented with a life-threatening crisis of warm <z:hpo ids='HP_0001890'>autoimmune hemolytic anemia</z:hpo> (AIHA) while under <z:hpo ids='HP_0011010'>chronic</z:hpo> low-dose steroid therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The exacerbation was eventually controlled with a 5-day course of intravenous immunoglobulin (IVIG, Sandoglobulin) (400 mg/kg per day) but <z:mp ids='MP_0010163'>hemolysis</z:mp> rapidly recurred, despite therapy with steroids, <z:chebi fb="2" ids="2948">azathioprine</z:chebi>, and cyclosporin, necessitating a second course of IVIG </plain></SENT>
<SENT sid="2" pm="."><plain>Control of packed cell transfusion needs for about 7 months was achieved by weekly administration of IVIG (800 mg/kg), although there is no direct evidence that IVIG therapy reduced the production of anticardiolipin or RBC antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>Three months after discontinuation of IVIG and change to maintenance with intermediate-dose <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> plus <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi>, the patient succumbed to duodenal <z:mpath ids='MPATH_81'>perforation</z:mpath> with <z:hpo ids='HP_0002586'>peritonitis</z:hpo> and <z:e sem="disease" ids="C0276653" disease_type="Disease or Syndrome" abbrv="">invasive pulmonary aspergillosis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The case illustrates that IVIG therapy may be helpful in selected life-threatening and refractory cases of AIHA </plain></SENT>
<SENT sid="5" pm="."><plain>It also sadly illustrates the long-term toxicity of standardly used therapeutics in refractory AIHA </plain></SENT>
</text></document>